A synthetic nutritional composition comprising choline for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.

A synthetic nutritional composition comprising choline for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.

A nutritional composition obtainable by fermenting a mixture comprising protein, carbohydrate and fat, wherein the major source of protein is potato protein, and wherein the mixture is fermented by lactic acid-producing bacteria.

A nutritional composition obtainable by fermenting a mixture comprising protein, carbohydrate and fat, wherein the major source of protein is potato protein, and wherein the mixture is fermented by lactic acid-producing bacteria.

Provided herein is an anti-allergic agent for ameliorating an allergic disease in infants, particularly newborns, without causing side effects. The anti-allergic agent for infants comprises a bifidobacterium.

The present application discloses a solid beverage for conditioning allergic constitution. The solid beverage comprises the following components in parts by weight: 18-45 parts of smoked plum, 10-30 parts of perilla, 18-45 parts of lilium brownii, 10-30 parts of purslane, 10-30 parts of coix seed, 10-30 parts of semen hoveniae, 7-20 parts of dahurian angelica, 15-40 parts of dextrin, 9-23 parts of maltodextrin, 9-23 parts of soluble starch and 0.1-0.3 parts of aspartame. The solid beverage of the present application is simple and convenient to prepare, the raw materials used are all medicinal materials with dual-purpose of drug and food, and the auxiliary materials used also meet the national standard GB2760-2011 (the National Food Safety Standard for Food Additive Use). Thus, the solid beverage is safe to consume and good in taste, and has certain effects on the improvement of allergic constitution, and the production process thereof is suitable for industrial mass production.

The present application discloses a solid beverage for conditioning allergic constitution. The solid beverage comprises the following components in parts by weight: 18-45 parts of smoked plum, 10-30 parts of perilla, 18-45 parts of lilium brownii, 10-30 parts of purslane, 10-30 parts of coix seed, 10-30 parts of semen hoveniae, 7-20 parts of dahurian angelica, 15-40 parts of dextrin, 9-23 parts of maltodextrin, 9-23 parts of soluble starch and 0.1-0.3 parts of aspartame. The solid beverage of the present application is simple and convenient to prepare, the raw materials used are all medicinal materials with dual-purpose of drug and food, and the auxiliary materials used also meet the national standard GB2760-2011 (the National Food Safety Standard for Food Additive Use). Thus, the solid beverage is safe to consume and good in taste, and has certain effects on the improvement of allergic constitution, and the production process thereof is suitable for industrial mass production.

Provided herein are compositions, foods comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof for modulating gluten intolerance and related conditions, such as celiac disease. Further provided herein are pharmaceutical compositions comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof to treat bacterial infections of the gastrointestinal tract, such as C. difficile or H. pylori. Further provided herein are compositions comprising recombinant nepenthesin I or nepenthesin II, or homologous proteins, and methods for making the same.

Provided herein are compositions, foods comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof for modulating gluten intolerance and related conditions, such as celiac disease. Further provided herein are pharmaceutical compositions comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof to treat bacterial infections of the gastrointestinal tract, such as C. difficile or H. pylori. Further provided herein are compositions comprising recombinant nepenthesin I or nepenthesin II, or homologous proteins, and methods for making the same.

The present invention is a novel composition including a fibrous protein having covered antigenicity, and the composition contains a complex prepared by bonding a fibrous protein such as tropomyosin derived from shrimp to a maltooligosaccharide such as maltopentaose or maltoheptaose through a Maillard reaction.